These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 31161848

  • 1. Thrombin-induced platelet aggregation -effect of dabigatran using automated platelet aggregometry.
    Shimizu M, Natori T, Tsuda K, Yoshida M, Kamada A, Oi K, Ishigaku Y, Oura K, Narumi S, Yamamoto M, Terayama Y.
    Platelets; 2020; 31(3):360-364. PubMed ID: 31161848
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
    Yamamoto J, Inoue N, Otsui K, Ishii H, Gorog DA.
    Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
    Olivier CB, Weik P, Meyer M, Weber S, Anto-Michel N, Diehl P, Zhou Q, Geisen U, Bode C, Moser M.
    Thromb Res; 2016 Feb; 138():63-68. PubMed ID: 26610745
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced TRAP-induced platelet aggregation with dabigatran - Clinical perspective.
    Bhagirath VC, Bosch J, Eikelboom JW.
    Thromb Res; 2016 Feb; 138():61-62. PubMed ID: 26757599
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of rivaroxaban and dabigatran on platelet functions: in vitro study.
    Jourdi G, Bachelot-Loza C, Mazoyer E, Poirault-Chassac S, Duchemin J, Fontenay M, Gaussem P.
    Thromb Res; 2019 Nov; 183():159-162. PubMed ID: 31678711
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors.
    Li ML, Ren YJ, Dong MH, Ren WX.
    Eur J Med Chem; 2015 Nov; 96():122-38. PubMed ID: 25874337
    [Abstract] [Full Text] [Related]

  • 14. Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux.
    Honda Y, Kamisato C, Morishima Y.
    Thromb Res; 2016 May; 141():17-21. PubMed ID: 26962981
    [Abstract] [Full Text] [Related]

  • 15. Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregation.
    Vanassche T, Kauskot A, Verhaegen J, Peetermans WE, van Ryn J, Schneewind O, Hoylaerts MF, Verhamme P.
    Thromb Haemost; 2012 Jun; 107(6):1107-21. PubMed ID: 22437005
    [Abstract] [Full Text] [Related]

  • 16. Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?
    Witkowski M, Steffens D, Hassanein A, Witkowski M, Kränkel N, Doerner A, Friebel J, Landmesser U, Rauch U.
    Thromb Res; 2017 Jan; 149():62-63. PubMed ID: 27907813
    [No Abstract] [Full Text] [Related]

  • 17. Impact of dabigatran on platelet function and fibrinolysis.
    Tsantes AE, Kyriakou E, Bonovas S, Chondrogianni M, Zompola C, Liantinioti C, Simitsi A, Katsanos AH, Atta M, Ikonomidis I, Kapsimali V, Kopterides P, Tsivgoulis G.
    J Neurol Sci; 2015 Oct 15; 357(1-2):204-8. PubMed ID: 26219486
    [Abstract] [Full Text] [Related]

  • 18. Thrombin Receptor Agonist Peptide-Induced Platelet Aggregation Is Reduced in Patients Receiving Dabigatran.
    Nehaj F, Sokol J, Mokan M, Ivankova J, Mokan M.
    Clin Appl Thromb Hemost; 2018 Mar 15; 24(2):268-272. PubMed ID: 28703014
    [Abstract] [Full Text] [Related]

  • 19. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM, Böger RH, Galland A, Frölich JC.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb 15; 357(2):143-50. PubMed ID: 9521487
    [Abstract] [Full Text] [Related]

  • 20. Design, Synthesis, and Biological Evaluation of Dabigatran Etexilate Mimics, a Novel Class of Thrombin Inhibitors.
    Wang S, Dai P, Xu Y, Chen Q, Zhu Q, Gong G.
    Arch Pharm (Weinheim); 2015 Aug 15; 348(8):595-605. PubMed ID: 26120827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.